rat bca cells nbt ii Search Results


rat anti mouse cxcl13 antibody mab 470  (R&D Systems)
92
R&D Systems rat anti mouse cxcl13 antibody mab 470
Effect on <t>CXCL13-</t> (A-D) and CXCL12- (negative control; E) induced migration of human and murine cells. Human pre-B-697-hCXCR5 cells (A, E) , human pre-B-697-hCXCR4 cells (E) , human tonsillar cells (B, E) , C57BL/6 splenocytes (C, E) , and SJL mouse splenocytes (D, E) were seeded into Transwell inserts. Diluted chemokines +/− antibodies were added into the lower chambers and plates were incubated for 2 h at 37°C (50 ug/ml of each antibody were used in CXCL12-induced migration assay). Inserts were removed and Alamar blue was added to the wells and incubated at 37°C overnight. Fluorescence was measured at wavelengths of 530 nm and 590 nm and the percent inhibition of chemokine-induced migration (A-D) or migration index (E) was calculated. Data represents an average of the measurements from at least three independent experiments + SEM. Statistical significance (relative to the isotype controls) was evaluated using one-way ANOVA followed by Bonferroni’s multiple comparison post test **** P < 0.0001; *** P < 0.0003; **P < 0.01.
Rat Anti Mouse Cxcl13 Antibody Mab 470, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bca+cells+nbt+ii/pmc04329654-164-36-42?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
rat anti mouse cxcl13 antibody mab 470 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
rat bca cells nbt ii  (ATCC)
94
ATCC rat bca cells nbt ii
Effect on <t>CXCL13-</t> (A-D) and CXCL12- (negative control; E) induced migration of human and murine cells. Human pre-B-697-hCXCR5 cells (A, E) , human pre-B-697-hCXCR4 cells (E) , human tonsillar cells (B, E) , C57BL/6 splenocytes (C, E) , and SJL mouse splenocytes (D, E) were seeded into Transwell inserts. Diluted chemokines +/− antibodies were added into the lower chambers and plates were incubated for 2 h at 37°C (50 ug/ml of each antibody were used in CXCL12-induced migration assay). Inserts were removed and Alamar blue was added to the wells and incubated at 37°C overnight. Fluorescence was measured at wavelengths of 530 nm and 590 nm and the percent inhibition of chemokine-induced migration (A-D) or migration index (E) was calculated. Data represents an average of the measurements from at least three independent experiments + SEM. Statistical significance (relative to the isotype controls) was evaluated using one-way ANOVA followed by Bonferroni’s multiple comparison post test **** P < 0.0001; *** P < 0.0003; **P < 0.01.
Rat Bca Cells Nbt Ii, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bca+cells+nbt+ii/pm41898771-178-31-35?v=ATCC
Average 94 stars, based on 1 article reviews
rat bca cells nbt ii - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
mouse monoclonal 125 cxcl3 antibody  (R&D Systems)
90
R&D Systems mouse monoclonal 125 cxcl3 antibody
Effect on <t>CXCL13-</t> (A-D) and CXCL12- (negative control; E) induced migration of human and murine cells. Human pre-B-697-hCXCR5 cells (A, E) , human pre-B-697-hCXCR4 cells (E) , human tonsillar cells (B, E) , C57BL/6 splenocytes (C, E) , and SJL mouse splenocytes (D, E) were seeded into Transwell inserts. Diluted chemokines +/− antibodies were added into the lower chambers and plates were incubated for 2 h at 37°C (50 ug/ml of each antibody were used in CXCL12-induced migration assay). Inserts were removed and Alamar blue was added to the wells and incubated at 37°C overnight. Fluorescence was measured at wavelengths of 530 nm and 590 nm and the percent inhibition of chemokine-induced migration (A-D) or migration index (E) was calculated. Data represents an average of the measurements from at least three independent experiments + SEM. Statistical significance (relative to the isotype controls) was evaluated using one-way ANOVA followed by Bonferroni’s multiple comparison post test **** P < 0.0001; *** P < 0.0003; **P < 0.01.
Mouse Monoclonal 125 Cxcl3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bca+cells+nbt+ii/pm32562707-156-41-48?v=R%26D+Systems
Average 90 stars, based on 1 article reviews
mouse monoclonal 125 cxcl3 antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
bcas3 antibody  (Abcepta)
N/A
   Buy from Supplier
phospho-bcar1 (tyr249) colorimetric cell-based elisa kit (okag01696)  (Aviva Systems)
N/A
   Buy from Supplier
abca5 antibody - c-terminal region (arp43688_p050)  (Aviva Systems)
N/A
This is a rabbit polyclonal antibody against ABCA5. It was validated on Western Blot using a cell lysate as a positive control. Aviva Systems Biology strives to provide antibodies covering each member of a whole
   Buy from Supplier
recombinant rat bcar1 protein  (Creative BioMart)
N/A
Recombinant Rat BCAR1 full length or partial length protein was expressed.http://www.creativebiomart.net/Recombinant-Rat-BCAR1-Protein-449774.htm
   Buy from Supplier
bcar1 (phospho-tyr249) colorimetric cell-based elisa kit  (Boster Bio)
N/A
The BCAR1 (Phospho-Tyr249) Cell-Based ELISA Kit is a convenient, lysate-free, high throughput and sensitive assay kit that can monitor BCAR1 (Phospho-Tyr249) protein expression profile in cells. The kit can be used for measuring the relative
   Buy from Supplier
phospho-bcar1 (tyr165) colorimetric cell-based elisa kit (okag01695)  (Aviva Systems)
N/A
   Buy from Supplier
anti-bcar1 mouse monoclonal antibody  (Boster Bio)
N/A
Boster Bio BCAR1 mouse monoclonal antibody, clone OTI1B1 (formerly 1B1). Catalog# M00960. Tested in FC, IF, IHC, WB. This antibody reacts with Human, Monkey, Mouse, Rat, Dog.
   Buy from Supplier
anti-bap31/bcap31 antibody picoband  (Boster Bio)
N/A
Boster Bio Anti-BAP31/BCAP31 Antibody Picoband® catalog # A03767-4. Tested in WB, IHC, ICC/IF, IP, Flow Cytometry, ELISA applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that
   Buy from Supplier
abca2 antibody (oaeb00290)  (Aviva Systems)
N/A
   Buy from Supplier

Image Search Results


Effect on CXCL13- (A-D) and CXCL12- (negative control; E) induced migration of human and murine cells. Human pre-B-697-hCXCR5 cells (A, E) , human pre-B-697-hCXCR4 cells (E) , human tonsillar cells (B, E) , C57BL/6 splenocytes (C, E) , and SJL mouse splenocytes (D, E) were seeded into Transwell inserts. Diluted chemokines +/− antibodies were added into the lower chambers and plates were incubated for 2 h at 37°C (50 ug/ml of each antibody were used in CXCL12-induced migration assay). Inserts were removed and Alamar blue was added to the wells and incubated at 37°C overnight. Fluorescence was measured at wavelengths of 530 nm and 590 nm and the percent inhibition of chemokine-induced migration (A-D) or migration index (E) was calculated. Data represents an average of the measurements from at least three independent experiments + SEM. Statistical significance (relative to the isotype controls) was evaluated using one-way ANOVA followed by Bonferroni’s multiple comparison post test **** P < 0.0001; *** P < 0.0003; **P < 0.01.

Journal: BMC Immunology

Article Title: CXCL13 antibody for the treatment of autoimmune disorders

doi: 10.1186/s12865-015-0068-1

Figure Lengend Snippet: Effect on CXCL13- (A-D) and CXCL12- (negative control; E) induced migration of human and murine cells. Human pre-B-697-hCXCR5 cells (A, E) , human pre-B-697-hCXCR4 cells (E) , human tonsillar cells (B, E) , C57BL/6 splenocytes (C, E) , and SJL mouse splenocytes (D, E) were seeded into Transwell inserts. Diluted chemokines +/− antibodies were added into the lower chambers and plates were incubated for 2 h at 37°C (50 ug/ml of each antibody were used in CXCL12-induced migration assay). Inserts were removed and Alamar blue was added to the wells and incubated at 37°C overnight. Fluorescence was measured at wavelengths of 530 nm and 590 nm and the percent inhibition of chemokine-induced migration (A-D) or migration index (E) was calculated. Data represents an average of the measurements from at least three independent experiments + SEM. Statistical significance (relative to the isotype controls) was evaluated using one-way ANOVA followed by Bonferroni’s multiple comparison post test **** P < 0.0001; *** P < 0.0003; **P < 0.01.

Article Snippet: In an attempt to decipher the mechanism of action of anti-CXCL13 antibody in animal models, Finch et al. [ ] examined the integrity of splenic architecture in BALB/c mice immunized with alum-precipitated DNP-OVA and treated with rat anti-mouse CXCL13 antibody MAb 470 (R&D Systems, clone 143614).

Techniques: Negative Control, Migration, Incubation, Fluorescence, Inhibition, Comparison

Inhibition of human CXCL13-mediated internalization of human CXCR5 receptor. Human pre-B-697-huCXCR5 cells were pre-blocked with anti-human Fc for 15 min at 37°C, incubated with a pre-complexed huCXCL13/antibody mix for 2 h at 37°C, and subsequently stained with anti-human CXCR5 antibody for flow cytometric analysis. (A) Cell surface CXCR5 receptor expression. Geometric mean values were determined by FlowJo 7.6 software. (B) EC50 values were calculated from sigmoidal dose response curves (shown on the graph) with R 2 values equal to 0.9 (MAb 5261) and 0.98 (MAb 5261-muIg). Data points represent an average of measurements obtained from 3 independent experiments.

Journal: BMC Immunology

Article Title: CXCL13 antibody for the treatment of autoimmune disorders

doi: 10.1186/s12865-015-0068-1

Figure Lengend Snippet: Inhibition of human CXCL13-mediated internalization of human CXCR5 receptor. Human pre-B-697-huCXCR5 cells were pre-blocked with anti-human Fc for 15 min at 37°C, incubated with a pre-complexed huCXCL13/antibody mix for 2 h at 37°C, and subsequently stained with anti-human CXCR5 antibody for flow cytometric analysis. (A) Cell surface CXCR5 receptor expression. Geometric mean values were determined by FlowJo 7.6 software. (B) EC50 values were calculated from sigmoidal dose response curves (shown on the graph) with R 2 values equal to 0.9 (MAb 5261) and 0.98 (MAb 5261-muIg). Data points represent an average of measurements obtained from 3 independent experiments.

Article Snippet: In an attempt to decipher the mechanism of action of anti-CXCL13 antibody in animal models, Finch et al. [ ] examined the integrity of splenic architecture in BALB/c mice immunized with alum-precipitated DNP-OVA and treated with rat anti-mouse CXCL13 antibody MAb 470 (R&D Systems, clone 143614).

Techniques: Inhibition, Incubation, Staining, Expressing, Software

Effect of murine anti-CXCL13 antibody on germinal center formation in C57BL/6 mice challenged with NP-KLH. Mice were treated with 30 mg/kg of MAb 5261-muIg antibody and corresponding mouse isotype control, on days −3, 0 (the day of the immunization), 4 and 7 (n = 9/group). (A) Total IgM and IgG1 anti-NP antibody-secreting cells were detected by ELISPOT on wells coated with NP14-BSA. (B) The frequencies of high affinity IgG1 anti-NP-secreting cells were determined by ELISPOT on wells coated with NP4-BSA. (C) Number of germinal centers (n = 9 mice/group). Follicles were hand counted. Number of PNA+ germinal centers in relation to total number of follicles per group was calculated using ImagePro software. (D) Mean germinal center area. Area of each PNA+ germinal center for each group was calculated using ImagePro software by PNA+ pixel area and then converted to μm. The numbers of GC analyzed were: 201 in Control group and 102 in MAb 5261-muIg-treated group. (E) Percentages of activated T cells (CD4+/CD62Llow/CD44+) in spleens and bone marrow. Statistical significance was evaluated by Student’s unpaired t -test. *P = 0.0125; **P = 0.0016; ****P < 0.0001; P = 0.2 and 0.71 for IgG1 and IgM portions of the graph, respectively (A) .

Journal: BMC Immunology

Article Title: CXCL13 antibody for the treatment of autoimmune disorders

doi: 10.1186/s12865-015-0068-1

Figure Lengend Snippet: Effect of murine anti-CXCL13 antibody on germinal center formation in C57BL/6 mice challenged with NP-KLH. Mice were treated with 30 mg/kg of MAb 5261-muIg antibody and corresponding mouse isotype control, on days −3, 0 (the day of the immunization), 4 and 7 (n = 9/group). (A) Total IgM and IgG1 anti-NP antibody-secreting cells were detected by ELISPOT on wells coated with NP14-BSA. (B) The frequencies of high affinity IgG1 anti-NP-secreting cells were determined by ELISPOT on wells coated with NP4-BSA. (C) Number of germinal centers (n = 9 mice/group). Follicles were hand counted. Number of PNA+ germinal centers in relation to total number of follicles per group was calculated using ImagePro software. (D) Mean germinal center area. Area of each PNA+ germinal center for each group was calculated using ImagePro software by PNA+ pixel area and then converted to μm. The numbers of GC analyzed were: 201 in Control group and 102 in MAb 5261-muIg-treated group. (E) Percentages of activated T cells (CD4+/CD62Llow/CD44+) in spleens and bone marrow. Statistical significance was evaluated by Student’s unpaired t -test. *P = 0.0125; **P = 0.0016; ****P < 0.0001; P = 0.2 and 0.71 for IgG1 and IgM portions of the graph, respectively (A) .

Article Snippet: In an attempt to decipher the mechanism of action of anti-CXCL13 antibody in animal models, Finch et al. [ ] examined the integrity of splenic architecture in BALB/c mice immunized with alum-precipitated DNP-OVA and treated with rat anti-mouse CXCL13 antibody MAb 470 (R&D Systems, clone 143614).

Techniques: Control, Enzyme-linked Immunospot, Software